Efficacy of Conversion Surgery Following Apatinib Plus Paclitaxel/S1 for Advanced Gastric Cancer With Unresectable Factors: A Multicenter, Single-Arm, Phase II Trial

Objective: Conversion therapy (surgical resection after chemotherapy) is a promising option for unresectable gastric cancer (GC) patients. Addition of anti-angiogenesis drug improves response to chemotherapy. Hence, this study explored the feasibility and efficacy of preoperative paclitaxel (PTX)/S1...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zhiyuan, Hu, Can, Yu, Jianfa, Du, Yian, Hu, Ping, Yu, Guofa, Hu, Conggang, Zhang, Yu, Mao, Wei, Chen, Shanqi, Cheng, Xiangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017219/
https://www.ncbi.nlm.nih.gov/pubmed/33815124
http://dx.doi.org/10.3389/fphar.2021.642511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017219/
https://www.ncbi.nlm.nih.gov/pubmed/33815124
http://dx.doi.org/10.3389/fphar.2021.642511

Ejemplares similares